NCT03280264 2021-05-27
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Phase 3 Completed
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Theraclion
Amgen